LactoBalance®

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.006291.05.15
Date of registration and renewal:12.05.2015
Dosage form: & nbspCapsules weighing 378 mg.
Classification "Composition" & nbsp Other dietary supplements Supplements - probiotics and prebiotics
Classification "Clinical" & nbsp Supplements promoting normalization and maintenance of normal intestinal microflora BAA, improving digestion and functional state of the digestive tract
Composition: & nbspComposition: Bifidobacterium bifidum G9-1, Bifidobacterium longum MM-2, Bifidobacterium longum M VV536, Bifidobacterium infantis M-3, Bifidobacterium breve M16V type T, Bifidobacterium lactis B1-04, Lactobacillus gasseri KS-13, Lactobacillus gasseri Lac-343, Lactobacillus rhamnosus LCS-742, E1400, gelatin, E551.
Scope: & nbspFor realization to the population as a biologically active additive to food - a source of probiotic microorganisms (bifido- and lactobacilli).
Suggested Usage: & nbspChildren from the age of 3 to 1 capsule 1 time per day with meals, adults 1 capsule 2 times a day with meals. Children from 3 years and adults who can not swallow the whole capsule, it is necessary to open it, pour the contents into a spoon and mix with a small amount of liquid. Duration of admission is up to 1 month.
Contraindications:Individual intolerance of components.
Special instructions:Before use, it is recommended to consult a doctor.
Children under 14 years old should be admitted in consultation with a doctor.
Shelf life:3 years in unopened packaging.
Storage conditions:Store in a dry place inaccessible to children, at a temperature not exceeding 25 ° C and relative humidity of not more than 60%.
After opening, store in a tightly closed bottle.
Does not require storage in the refrigerator.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.11.003.Е.005005.03.15 of 24.03.2015, the expert opinion of the Federal State Research Institution "NII Nutrition" №72 / Э-1470 / б-14 of 18.12.2014.
Recipient:Unifarm Inc., Representative Office of the Corporation (USA)Unifarm Inc., Representative Office of the Corporation (USA) Russia
Information update date: & nbsp26.06.2016
Instructions
Up